Aarkstore.com announces- 15% Discount on-Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues
Aark-Store announces, The Latest market research report is available in its vast collection:
Generic Growth Strategies – Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues
Company has released its research “Generic Growth Strategies – Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues”. It provides a comprehensive overview of the generic drugs market, analysis of upcoming noteworthy patent expirations, and trends and issues facing the generics market. The report delves into much detail on the current landscape; changes that have structured the generic drugs market in the last 30 years; and the reason behind the players’ urgency in developing and implementing generic growth strategies. The report also contains impact analysis of the regulatory landscape in the major geographies pertaining to the generic drugs market. Major strategies adopted by the leading companies in the generic drugs market have been analyzed in much detail, along with an elaborate company portfolio and strategic analysis of leading generic players.
The scope of this report includes –
- Detailed study of generic growth strategies with special emphasis on strategies which help in combating intensive competition.
- Analysis of the major strategies adopted by companies looking to expand geographical reach.
- Case studies of successful generic growth strategies.
- Competitive profiling of leading companies. The key companies studied in this report are Teva, Sandoz, Hospira, Watson, Mylan, Perrigo, STADA, DRL, Par, Apotex and Actavis.
Table of contents:
1.1 List of Tables 5
1.2 List of Figures 5
2 Generic Growth Strategies: Introduction 6
2.1 Company Report Guidance 7
3 Generic Growth Strategies: Market Overview 8
3.1 Overview of the Generics Market 8
3.2 Patent Expiries – Peak Years 8
3.3 Patent Expiration of Blockbuster Drugs, By Therapeutic Area 10
3.4 Upcoming Patent Expiries 11
3.5 Trends and Issues 11
3.5.1 ANDA Filings and Approvals are on the Rise 11
3.5.2 European Market for Small Molecule Generic Drugs versus Biosimilars 13
3.5.3 Untapped Generics Market in Certain European Countries 14
3.5.4 Biosimilars Focus – Innovators as Well as Generics Companies 15
List of Figures
List of Tables are also include.
For more DISCOUNT related Reports Plz follow The link:
Rx-to-OTC Switching Strategies – New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge
Antifungals Market to 2017 – Generic Erosion of Major Polyenes, Azoles, Allylamines and Echinocandins to Slow Value Growth
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1
Biobetters in Key Markets – Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings
You can also request for sample page of above mention reports on email@example.com
For More details Plz do contact :
ListFree.org: Embedded data.
|Contact us at :|